Alicia Báez, Beatriz Martín-Antonio, José I

Slides:



Advertisements
Similar presentations
A Simplified Procedure for Hematopoietic Stem Cell Amplification Using a Serum-Free, Feeder Cell-Free Culture System Ian M. Rogers, Nobuko Yamanaka, Robert.
Advertisements

Galactomannan Antigen Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation  Patrick.
Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation  Sarah J. Kizilbash, Clifford E. Kashtan,
Adverse Clinical Consequences of Hyperglycemia from Total Parenteral Nutrition Exposure during Hematopoietic Stem Cell Transplantation  Patricia M. Sheean,
Challenges around Access to and Cost of Life-Saving Medications after Allogeneic Hematopoietic Cell Transplantation for Medicare Patients  Stephanie Farnia,
Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation  María.
Increased Plasma Indoleamine 2,3-Dioxygenase Activity and Interferon-γ Levels Correlate with the Severity of Acute Graft-versus-Host Disease after Allogeneic.
Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplantation Clinical Trials  Ellen M. Denzen, Martha E. Burton Santibáñez, Heather Moore,
How to Treat MDS without Stem Cell Transplantation
The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma  Mehdi Hamadani, Erinn Hade, Don M. Benson,
IV Busulfan Dose Individualization in Children undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies  L. Lee Dupuis, Cathryn Sibbald,
Thymic Activity and T Cell Repertoire Recovery after Autologous Hematopoietic Stem Cell Transplantation Preceded by Myeloablative Radiotherapy or Chemotherapy 
Vaccination of Children following Allogeneic Stem Cell Transplantation
Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortion  Weibing Qin, M.D., Ph.D., Yunge Tang, M.D., Ning.
Allogeneic Stem Cell Transplantation in Myelofibrosis
A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to.
Adverse Clinical Consequences of Hyperglycemia from Total Parenteral Nutrition Exposure during Hematopoietic Stem Cell Transplantation  Patricia M. Sheean,
Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and.
Sabina Kersting, Leo F. Verdonck 
Suppression of natural killer cells in the presence of CD34+ blood progenitor cells and peripheral blood lymphocytes  J. Clausen, M. Enk, B. Vergeiner,
Access to Hematopoietic Cell Transplantation in the United States
Betty T. Tran, Abigail Halperin, Jason W. Chien 
Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation 
Caroline F. Morrison, Donna M
The Pretransplantation Serum Cytokine Profile in Allogeneic Stem Cell Recipients Differs from Healthy Individuals, and Various Profiles are Associated.
Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source  Sharat Damodar,
J. J. Nietfeld, Marcelo C. Pasquini, Brent R
Christopher C. Dvorak, Rajni Agarwal, Gary V. Dahl, John J
New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation  Anita D'Souza,
A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model  Justin N. Baker,
Controversies in Lymphoma: The Role of Hematopoietic Cell Transplantation for Mantle Cell Lymphoma and Peripheral T Cell Lymphoma  Peter Dreger, Ginna.
Time to Insurance Approval in Private and Public Payers Does Not Influence Survival in Patients Who Undergo Hematopoietic Cell Transplantation  Vijaya.
Helicobacter pylori Infection and Graft-versus-Host Disease
Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation  Laurie H. Sehn, Timothy S. Fenske, Ginna G. Laport 
MicroRNA Methylation Profile Has Prognosis Impact in Acute Lymphoblastic Leukemia Patients Undergoing Stem Cell Transplantation  Vanesa Martín-Palanco,
Improvement of Pulmonary Function with Imatinib Mesylate in Bronchiolitis Obliterans Following Allogeneic Hematopoietic Cell Transplantation  Navneet.
Quantitation of Human Cells that Produce Neutrophils and Platelets in Vivo Obtained from Normal Donors Treated with Granulocyte Colony–Stimulating Factor.
B Cells and Transplantation: An Educational Resource
Sarah A. Holstein, Paul G. Richardson, Jacob P. Laubach, Philip L
Pharmacokinetic Evaluation of the Drug Interaction between Intravenous Itraconazole and Intravenous Tacrolimus or Intravenous Cyclosporin A in Allogeneic.
Iron Overload Manifesting as Apparent Exacerbation of Hepatic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation  Rammurti.
Sabina Kersting, Ronald J. Hené, Hein A. Koomans, Leo F. Verdonck 
Predonation Health-Related Quality of Life Scores Predict Time to Recovery in Hematopoietic Stem Cell Donors  Annelies Billen, J. Alejandro Madrigal,
Allogeneic Stem Cell Transplantation for Aplastic Anemia
Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation  Sarah J. Kizilbash, Clifford E. Kashtan,
Comparative Analysis: Trend of Infectious Complications in Cord Blood (CB) Versus Peripheral Blood (PB) and Bone Marrow (BM) Stem Cell Transplant (SCT)
The Hematopoietic Cell Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the ASBMT Pharmacy Special Interest Group  Amber B. Clemmons,
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
Pauline Damien, David S. Allan 
ASBMT and CBMTG Release Choosing Wisely BMT Recommendations
Galactomannan Antigen Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation  Patrick.
Gerard Socié, K. Scott Baker, Smita Bhatia 
What is quality in a transplant program?
MiRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma  Daniel.
Issues of Aging and Geriatric Medicine: Relevance to Cancer Treatment and Hematopoietic Reconstitution  William B. Ershler, Andrew S. Artz, Evan T. Keller 
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond  Stanley R. Riddell, Michael C. Jensen, Carl.
Improving the Informed Consent Process in Hematopoietic Cell Transplantation: Patient, Caregiver, and Provider Perspectives  Minakshi Raj, Sung Won Choi,
Blood and Marrow Transplant Handbook
Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Better Prognosis Than Systemic Relapse 
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives  Brenda M. Sandmaier, Stephen Mackinnon, Richard.
Treatment versus Transplant for Challenging Hematologic Disorders
Gene Profiling of Keloid Fibroblasts Shows Altered Expression in Multiple Fibrosis- Associated Pathways  Joan C. Smith, Braden E. Boone, Susan R. Opalenik,
Mary Eapen  Biology of Blood and Marrow Transplantation 
Futility of Relapsed Diffuse Large B Cell Lymphoma Transplantation?
Correlation of Infused CD3+CD8+ Cells with Single-Donor Dominance after Double-Unit Cord Blood Transplantation  Filippo Milano, Shelly Heimfeld, Ted Gooley,
In Memoriam: E. Donnall Thomas
Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience  Andy I. Chen, Alex McMillan,
Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma  Luciano J. Costa, Jia-Xing Huang, Parameswaran.
Presentation transcript:

Gene and miRNA Expression Profiles of Hematopoietic Progenitor Cells Vary Depending on Their Origin  Alicia Báez, Beatriz Martín-Antonio, José I. Piruat, Maria Victoria Barbado, Concepción Prats, Isabel Álvarez-Laderas, Magdalena Carmona, José Antonio Pérez-Simón, Álvaro Urbano-Ispizua  Biology of Blood and Marrow Transplantation  Volume 20, Issue 5, Pages 630-639 (May 2014) DOI: 10.1016/j.bbmt.2014.01.022 Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 miRNA expression by HPC source. Unsupervised hierarchical cluster analysis performed with the miRNAs differentially expressed in HPCs from G-PB, BM, and CB. Each numbered column represents an individual sample, and each row represents a single miRNA. Red and green indicate miRNA expression levels in logarithmic scale. Statistical analysis was performed using the nonparametric Kruskal-Wallis test. Biology of Blood and Marrow Transplantation 2014 20, 630-639DOI: (10.1016/j.bbmt.2014.01.022) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Gene expression by HPC source. Unsupervised hierarchical cluster analysis performed with the genes differentially expressed in HPCs from G-PB, BM, and CB. Each numbered column represents an individual sample, and each row represents a single gene. Red and green indicate gene expression levels in logarithmic scale. Statistical analysis was performed using the nonparametric Kruskal-Wallis test. Biology of Blood and Marrow Transplantation 2014 20, 630-639DOI: (10.1016/j.bbmt.2014.01.022) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Validation of significant genes. Expression levels of genes differentially expressed in HPCs from G-PB, BM, and CB relative to HPCs from PB as determined by qRT-PCR. Statistical analysis was performed with ANOVA. *P < .01. Biology of Blood and Marrow Transplantation 2014 20, 630-639DOI: (10.1016/j.bbmt.2014.01.022) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Gene expression pattern by HPC source versus PB. Unsupervised hierarchical cluster analysis was performed with the genes differentially expressed in G-PB versus PB (A), CB versus PB (B), and BM versus PB (C). Each numbered column represents an individual sample, and each row represents a single gene. Red and green indicate gene expression levels in logarithmic scale. Statistical analysis was performed using the nonparametric Mann-Whitney test. Biology of Blood and Marrow Transplantation 2014 20, 630-639DOI: (10.1016/j.bbmt.2014.01.022) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 miRNA expression pattern in HPC sources versus PB. Unsupervised hierarchical cluster analysis was performed with the miRNAs differentially expressed in G-PB versus PB (A), CB versus PB (B), and BM versus PB (C). Each numbered column represents an individual sample, and each row represents a single miRNA. Red and green indicate gene expression levels in logarithmic scale. Statistical analysis was performed using the nonparametric Mann-Whitney test. Biology of Blood and Marrow Transplantation 2014 20, 630-639DOI: (10.1016/j.bbmt.2014.01.022) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 Protein expression by HPC source. (A) Western blot analysis of HSPA1A and CRLF3 proteins comparing HPCs from G-PB, BM, and CB. (B and C) Protein levels of HSPA1A (B) and CRLF3 (C) in HPCs from G-PB, BM, and CB normalized with respect to β-actin (n = 2). Biology of Blood and Marrow Transplantation 2014 20, 630-639DOI: (10.1016/j.bbmt.2014.01.022) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions